Science Daily: Pharmacology News
APRIL 10, 2024
In a new breakthrough that could revolutionise medical and material engineering, scientists have developed a first-of-its-kind molecular device that controls the release of multiple small molecules using force.
BioPharma Drive: Drug Pricing
APRIL 10, 2024
The first medicine approved for PPD, Sage’s Zulresso, never gained traction. The company is in the midst of launching its second, but long-standing challenges could slow uptake.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Science Daily: Pharmacology News
APRIL 10, 2024
Findings show a newly created drug can prevent runaway inflammation while still allowing the immune system to handle the virus, even when given late into infection.
BioPharma Drive: Drug Pricing
APRIL 10, 2024
The deal, which company CEO Reshma Kewalramani described as “just the right fit,” is the largest acquistion in Vertex’s 35-year history.
Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
Science Daily: Pharmacology News
APRIL 10, 2024
Undertaking the majority of daily physical activity in the evening is linked to the greatest health benefits for people living with obesity, according to researchers who followed the trajectory of 30,000 people over almost 8 years.
Drug Discovery Digest brings together the best content for drug research and development professionals from the widest variety of industry thought leaders.
Science Daily: Pharmacology News
APRIL 10, 2024
A new study reveals the detailed protein structure of the TAS2R14, a bitter taste receptor that allows us to perceive bitter taste. In addition to solving the structure of this taste receptor, the researchers were also able to determine where bitter-tasting substances bind to TAS2R14 and how they activate them. The findings may lead to the development of drugs that targeting taste receptors.
Drugs.com
APRIL 10, 2024
WEDNESDAY, April 10, 2024 -- Wegovy, Ozempic and other drugs known as GLP-1 analogues have become wildly popular for controlling diabetes and helping folks lose weight.There were concerns that longer term use of the drugs might raise users' odds.
Science Daily: Pharmacology News
APRIL 10, 2024
Astrophysicists shed light on the relationship between the Milky Way and the Egyptian sky-goddess Nut. The paper draws on ancient Egyptian texts and simulations to argue that the Milky Way might have shone a spotlight, as it were, on Nut's role as the sky. It proposes that in winter, the Milky Way highlighted Nut's outstretched arms, while in summer, it traced her backbone across the heavens.
Drugs.com
APRIL 10, 2024
WEDNESDAY, April 10, 2024 -- A new drug can slash triglyceride levels nearly in half by targeting a genetic driver of high fat levels in the bloodstream, researchers said. The injectable drug, olezarsen, lowered triglyceride levels by 49% at the 50.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Science Daily: Pharmacology News
APRIL 10, 2024
Cortisone and other related glucocorticoids are extremely effective at curbing excessive immune reactions. But previously, astonishingly little was known about how they exactly do that. Researchers have now explored the molecular mechanism of action in greater detail. As the researchers report, glucocorticoids reprogram the metabolism of immune cells, activating the body's natural 'brakes' on inflammation.
Drugs.com
APRIL 10, 2024
WEDNESDAY, April 10, 2024 -- A new drug can slash triglyceride levels nearly in half by targeting a genetic driver of high fat levels in the bloodstream, researchers said.The injectable drug, olezarsen, lowered triglyceride levels by 49% at the 50.
Science Daily: Pharmacology News
APRIL 10, 2024
Researchers have developed a digital display screen where the LEDs themselves react to touch, light, fingerprints and the user's pulse, among other things. Their results could be the start of a whole new generation of displays for phones, computers and tablets.
Drugs.com
APRIL 10, 2024
WEDNESDAY, April 10, 2024 -- Phillips Respironics, the company responsible for the recall of millions of defective sleep apnea machines since 2021, must overhaul its production of the machines before it can resume making them in the United States,
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Science Daily: Pharmacology News
APRIL 10, 2024
Researchers have developed a technique to connect lab-grown neural 'organoids' (three-dimensional developmental brain-like structures grown from human stem cells) using axonal bundles, similar to the connections between regions in the human brain. This technique allows brain networks to be better represented experimentally in the lab, and will improve understanding and studies of network-related brain disorders.
Drugs.com
APRIL 10, 2024
WEDNESDAY, April 10, 2024 -- Early-onset arthritis may hit as many as one in every four young people who undergo anterior cruciate ligament (ACL) reconstruction surgeries, new research warns.The arthritic pain emerges within 6 to 12 months.
Science Daily: Pharmacology News
APRIL 10, 2024
New evidence of one of the first cities in the Pacific shows they were established much earlier than previously thought, according to new research. The study used aerial laser scanning to map archaeological sites on the island of Tongatapu in Tonga, showing Earth structures were being constructed in Tongatapu around AD 300.
Drugs.com
APRIL 10, 2024
WEDNESDAY, April 10, 2024 -- The Environmental Protection Agency announced Wednesday that it has finalized a first-ever rule that will drastically lower the amount of PFAS, also known as "forever chemicals," in the nation's drinking.
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
Science Daily: Pharmacology News
APRIL 10, 2024
Early jawless fish were likely to have used bony projections surrounding their mouths to modify the mouth's shape while they collected food. Experts have used CT scanning techniques to build up the first 3D pictures of these creatures, which are some of the earliest vertebrates (animals with backbones) in which the mouth is fossilized. Their aim was to answer questions about feeding in early vertebrates without jaws in the early Devonian epoch -- sometimes called the Age of Fishes -- around 400
Drugs.com
APRIL 10, 2024
WEDNESDAY, April 10, 2024 -- Teenagers suffering from anxiety, depression or bipolar disorder are likely to have a tougher time getting their driver’s license, a new study finds.Teens and young adults with these types of mood disorders are 30%.
BioPharma Drive: Drug Pricing
APRIL 10, 2024
The biotech is working on a preventive therapy for the immune disorder, known as FNAIT for short, while J&J is studying its drug nipocalimab as a treatment.
Drugs.com
APRIL 10, 2024
WEDNESDAY, April 10, 2024 -- Most seniors have embraced “doc-in-a-box” strip mall clinics and urgent care centers as a means of getting prompt medical care, a new poll has found.About 60% of people ages 50 to 80 have visited an urgent care.
Advertisement
Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic
NIOSH Science Blog: Drugs
APRIL 10, 2024
Struck-by injuries are the leading cause of nonfatal injuries and second most common cause of fatalities among construction workers. From 2011 to 2022, there were 1,462 fatal occupational injuries that occurred at road construction sites.[1] Of these, 68% (n=1,000) were among workers in the construction industry (See figure) followed by workers in transportation and warehousing (11%; n=168) and professional and business services (9%; n=132) industries.
Drugs.com
APRIL 10, 2024
WEDNESDAY, April 10, 2024 -- Beta blockers appear to be useless when prescribed to heart attack survivors who aren't suffering from heart failure, a new clinical trial indicates.The study calls into question the routine of prescribing beta blockers.
NIOSH Science Blog: Drugs
APRIL 10, 2024
Work-related psychosocial hazards are factors in the work environment that can cause stress, strain, or interpersonal problems for the worker. This has the potential to cause physical and psychological harm. Work-related psychosocial hazards are on the verge of surpassing many other occupational hazards in terms of their contribution to poor health, injury, disability, and costs.[1][2][3][4] The extensive and cumulative impacts of these exposures represent an alarming public health problem that
Drugs.com
APRIL 10, 2024
WEDNESDAY, April 10, 2024 -- The “gig economy” could be setting up many young adults for drinking problems later in life, a new study warns.People who take poorly paid temp jobs as freelancers or independent contractors are 43% more likely to.
Perficient: Drug Development
APRIL 10, 2024
The winds of change are blowing in the world of commerce, and composable architecture is taking center stage. Businesses are ditching monolithic platforms and embracing the freedom to mix and match best-of-breed solutions to create unique and engaging shopping experiences using MACH and Composable architecture. Composable commerce takes headless architecture further.
Cytel
APRIL 10, 2024
Orphan drug designation is a regulatory status granted to pharmaceuticals developed for the treatment of rare diseases. It provides incentives to encourage the research, development, and approval of therapies targeting small patient populations.
Metabolite Tales Blog
APRIL 10, 2024
Metabolism of 2023 FDA Approved Small Molecules – PART 2 A focus on drugs where metabolism in humans results in circulating glucuronides and other conjugates By Julia Shanu-Wilson Following on from our first delve into the metabolism of small molecule drugs approved last year where active metabolites were reported, we now look at a subset of drugs where phase II mechanisms are involved.
Fierce BioTech
APRIL 10, 2024
Redefining Antibody Specificity Profiling for IND swheeler Wed, 04/10/2024 - 17:56 Thu, 06/06/2024 - 11:00 Resource Type Webinar Kris Raghavan, PhD Fernanda I. Staquicini, PhD Duration 60 minutes Assessment of antibody off-target reactivity is a regulatory requirement for clinical development. However, conventional screening methods, such as tissue cross-reactivity studies, are often ineffective in screening newer therapeutic modalities, and their predictive value for in vivo safety and toxicity
Expert insights. Personalized for you.
348 
Let's personalize your content